BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Caulin C, Nguyen T, Lang GA, Goepfert TM, Brinkley BR, Cai WW, Lozano G, Roop DR. An inducible mouse model for skin cancer reveals distinct roles for gain- and loss-of-function p53 mutations. J Clin Invest 2007;117:1893-901. [PMID: 17607363 DOI: 10.1172/JCI31721] [Cited by in Crossref: 96] [Cited by in F6Publishing: 93] [Article Influence: 6.4] [Reference Citation Analysis]
Number Citing Articles
1 Gaviria Agudelo C, Restrepo LM. Human Skin Cancer: an Overview Of Animal, Ex Vivo, and In Vitro Models. Curr Derm Rep. [DOI: 10.1007/s13671-022-00361-w] [Reference Citation Analysis]
2 Marjanovic J, Ramirez HA, Jozic I, Stone RC, Wikramanayake TC, Head CR, Abdo Abujamra B, Ojeh N, Kirsner RS, Lev-Tov H, Pastar I, Tomic-Canic M. Dichotomous role of miR193b-3p in diabetic foot ulcers maintains inhibition of healing and suppression of tumor formation. Sci Transl Med 2022;14:eabg8397. [PMID: 35544594 DOI: 10.1126/scitranslmed.abg8397] [Reference Citation Analysis]
3 Haraoka Y, Akieda Y, Nagai Y, Mogi C, Ishitani T. Zebrafish imaging reveals TP53 mutation switching oncogene-induced senescence from suppressor to driver in primary tumorigenesis. Nat Commun 2022;13:1417. [PMID: 35304872 DOI: 10.1038/s41467-022-29061-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
4 Piipponen M, Riihilä P, Nissinen L, Kähäri VM. The Role of p53 in Progression of Cutaneous Squamous Cell Carcinoma. Cancers (Basel) 2021;13:4507. [PMID: 34572732 DOI: 10.3390/cancers13184507] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
5 Li K, Liao N, Chen B, Zhang G, Wang Y, Guo L, Wei G, Jia M, Wen L, Ren C, Cao L, Mok H, Li C, Lin J, Chen X, Zhang Z, Hou T, Li M, Liu J, Balch CM, Liao N. Genetic mutation profile of Chinese HER2-positive breast cancers and genetic predictors of responses to Neoadjuvant anti-HER2 therapy. Breast Cancer Res Treat 2020;183:321-32. [PMID: 32638235 DOI: 10.1007/s10549-020-05778-0] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Gualandi M, Iorio M, Engeler O, Serra-Roma A, Gasparre G, Schulte JH, Hohl D, Shakhova O. Oncogenic ALK F1174L drives tumorigenesis in cutaneous squamous cell carcinoma. Life Sci Alliance 2020;3:e201900601. [PMID: 32312912 DOI: 10.26508/lsa.201900601] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
7 Omori H, Nishio M, Masuda M, Miyachi Y, Ueda F, Nakano T, Sato K, Mimori K, Taguchi K, Hikasa H, Nishina H, Tashiro H, Kiyono T, Mak TW, Nakao K, Nakagawa T, Maehama T, Suzuki A. YAP1 is a potent driver of the onset and progression of oral squamous cell carcinoma. Sci Adv 2020;6:eaay3324. [PMID: 32206709 DOI: 10.1126/sciadv.aay3324] [Cited by in Crossref: 19] [Cited by in F6Publishing: 36] [Article Influence: 9.5] [Reference Citation Analysis]
8 Roszkowska KA, Gizinski S, Sady M, Gajewski Z, Olszewski MB. Gain-of-Function Mutations in p53 in Cancer Invasiveness and Metastasis. Int J Mol Sci 2020;21:E1334. [PMID: 32079237 DOI: 10.3390/ijms21041334] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
9 Amit M, Takahashi H, Dragomir MP, Lindemann A, Gleber-Netto FO, Pickering CR, Anfossi S, Osman AA, Cai Y, Wang R, Knutsen E, Shimizu M, Ivan C, Rao X, Wang J, Silverman DA, Tam S, Zhao M, Caulin C, Zinger A, Tasciotti E, Dougherty PM, El-Naggar A, Calin GA, Myers JN. Loss of p53 drives neuron reprogramming in head and neck cancer. Nature 2020;578:449-54. [PMID: 32051587 DOI: 10.1038/s41586-020-1996-3] [Cited by in Crossref: 71] [Cited by in F6Publishing: 95] [Article Influence: 35.5] [Reference Citation Analysis]
10 Stein Y, Rotter V, Aloni-Grinstein R. Gain-of-Function Mutant p53: All the Roads Lead to Tumorigenesis. Int J Mol Sci 2019;20:E6197. [PMID: 31817996 DOI: 10.3390/ijms20246197] [Cited by in Crossref: 39] [Cited by in F6Publishing: 49] [Article Influence: 13.0] [Reference Citation Analysis]
11 Tang J, Feng Y, Kuick R, Green M, Green M, Sakamoto N, Kurosu Y, Lin J, Cho KR, Fearon ER. Trp53 null and R270H mutant alleles have comparable effects in regulating invasion, metastasis, and gene expression in mouse colon tumorigenesis. Lab Invest 2019;99:1454-69. [PMID: 31148594 DOI: 10.1038/s41374-019-0269-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
12 Goldie SJ, Chincarini G, Darido C. Targeted Therapy Against the Cell of Origin in Cutaneous Squamous Cell Carcinoma. Int J Mol Sci 2019;20:E2201. [PMID: 31060263 DOI: 10.3390/ijms20092201] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
13 Ryan WK, Fernandez J, Peterson MK, Sheneman DW, Podell BK, De S, Torchia EC. Activation of S6 signaling is associated with cell survival and multinucleation in hyperplastic skin after epidermal loss of AURORA-A Kinase. Cell Death Differ 2019;26:548-64. [PMID: 30050055 DOI: 10.1038/s41418-018-0167-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
14 Olivero C, Lanfredini S, Borgogna C, Gariglio M, Patel GK. HPV-Induced Field Cancerisation: Transformation of Adult Tissue Stem Cell Into Cancer Stem Cell. Front Microbiol 2018;9:546. [PMID: 29632522 DOI: 10.3389/fmicb.2018.00546] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
15 Li YR, Yang WX. Myosins as fundamental components during tumorigenesis: diverse and indispensable. Oncotarget 2016;7:46785-812. [PMID: 27121062 DOI: 10.18632/oncotarget.8800] [Cited by in Crossref: 27] [Cited by in F6Publishing: 34] [Article Influence: 6.8] [Reference Citation Analysis]
16 Page A, Navarro M, Suarez-Cabrera C, Alameda JP, Casanova ML, Paramio JM, Bravo A, Ramirez A. Protective role of p53 in skin cancer: Carcinogenesis studies in mice lacking epidermal p53. Oncotarget 2016;7:20902-18. [PMID: 26959115 DOI: 10.18632/oncotarget.7897] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
17 Popis MC, Wagner RE, Constantino-Casas F, Blanco S, Frye M. Considerations for skin carcinogenesis experiments using inducible transgenic mouse models. BMC Res Notes 2018;11:67. [PMID: 29361972 DOI: 10.1186/s13104-018-3182-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
18 Zhou R, Xu A, Gingold J, Strong LC, Zhao R, Lee DF. Li-Fraumeni Syndrome Disease Model: A Platform to Develop Precision Cancer Therapy Targeting Oncogenic p53. Trends Pharmacol Sci 2017;38:908-27. [PMID: 28818333 DOI: 10.1016/j.tips.2017.07.004] [Cited by in Crossref: 19] [Cited by in F6Publishing: 24] [Article Influence: 3.8] [Reference Citation Analysis]
19 Till JE, Yoon C, Kim BJ, Roby K, Addai P, Jonokuchi E, Tang LH, Yoon SS, Ryeom S. Oncogenic KRAS and p53 Loss Drive Gastric Tumorigenesis in Mice That Can Be Attenuated by E-Cadherin Expression. Cancer Res 2017;77:5349-59. [PMID: 28760854 DOI: 10.1158/0008-5472.CAN-17-0061] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 3.4] [Reference Citation Analysis]
20 Youssef M, Cuddihy A, Darido C. Long-Lived Epidermal Cancer-Initiating Cells. Int J Mol Sci 2017;18:E1369. [PMID: 28654000 DOI: 10.3390/ijms18071369] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
21 Pfister NT, Prives C. Transcriptional Regulation by Wild-Type and Cancer-Related Mutant Forms of p53. Cold Spring Harb Perspect Med 2017;7:a026054. [PMID: 27836911 DOI: 10.1101/cshperspect.a026054] [Cited by in Crossref: 49] [Cited by in F6Publishing: 56] [Article Influence: 9.8] [Reference Citation Analysis]
22 Shetzer Y, Molchadsky A, Rotter V. Oncogenic Mutant p53 Gain of Function Nourishes the Vicious Cycle of Tumor Development and Cancer Stem-Cell Formation. Cold Spring Harb Perspect Med 2016;6:a026203. [PMID: 27235476 DOI: 10.1101/cshperspect.a026203] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 4.7] [Reference Citation Analysis]
23 Hetmanski JH, Zindy E, Schwartz JM, Caswell PT. A MAPK-Driven Feedback Loop Suppresses Rac Activity to Promote RhoA-Driven Cancer Cell Invasion. PLoS Comput Biol 2016;12:e1004909. [PMID: 27138333 DOI: 10.1371/journal.pcbi.1004909] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 5.3] [Reference Citation Analysis]
24 Poulou M, Mandalos NP, Karnavas T, Saridaki M, McKay RD, Remboutsika E. A "Hit and Run" Approach to Inducible Direct Reprogramming of Astrocytes to Neural Stem Cells. Front Physiol 2016;7:127. [PMID: 27148066 DOI: 10.3389/fphys.2016.00127] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
25 Kamp WM, Wang PY, Hwang PM. TP53 mutation, mitochondria and cancer. Curr Opin Genet Dev 2016;38:16-22. [PMID: 27003724 DOI: 10.1016/j.gde.2016.02.007] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 5.2] [Reference Citation Analysis]
26 Valenti F, Ganci F, Fontemaggi G, Sacconi A, Strano S, Blandino G, Di Agostino S. Gain of function mutant p53 proteins cooperate with E2F4 to transcriptionally downregulate RAD17 and BRCA1 gene expression. Oncotarget 2015;6:5547-66. [PMID: 25650659 DOI: 10.18632/oncotarget.2587] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 5.3] [Reference Citation Analysis]
27 Paul NR, Allen JL, Chapman A, Morlan-Mairal M, Zindy E, Jacquemet G, Fernandez del Ama L, Ferizovic N, Green DM, Howe JD, Ehler E, Hurlstone A, Caswell PT. α5β1 integrin recycling promotes Arp2/3-independent cancer cell invasion via the formin FHOD3. J Cell Biol 2015;210:1013-31. [PMID: 26370503 DOI: 10.1083/jcb.201502040] [Cited by in Crossref: 76] [Cited by in F6Publishing: 67] [Article Influence: 10.9] [Reference Citation Analysis]
28 Sabapathy K. The Contrived Mutant p53 Oncogene - Beyond Loss of Functions. Front Oncol 2015;5:276. [PMID: 26697411 DOI: 10.3389/fonc.2015.00276] [Cited by in Crossref: 21] [Cited by in F6Publishing: 26] [Article Influence: 3.0] [Reference Citation Analysis]
29 Li Y, Lei D, Swindell WR, Xia W, Weng S, Fu J, Worthen CA, Okubo T, Johnston A, Gudjonsson JE, Voorhees JJ, Fisher GJ. Age-Associated Increase in Skin Fibroblast-Derived Prostaglandin E2 Contributes to Reduced Collagen Levels in Elderly Human Skin. J Invest Dermatol 2015;135:2181-8. [PMID: 25905589 DOI: 10.1038/jid.2015.157] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 4.7] [Reference Citation Analysis]
30 Said R, Ye Y, Hong DS, Janku F, Fu S, Naing A, Wheler JJ, Kurzrock R, Thomas C, Palmer GA, Hess KR, Aldape K, Tsimberidou AM. Characteristics and survival of patients with advanced cancer and p53 mutations. Oncotarget 2014;5:3871-9. [PMID: 25003695 DOI: 10.18632/oncotarget.2004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
31 Huang PY, Balmain A. Modeling cutaneous squamous carcinoma development in the mouse. Cold Spring Harb Perspect Med 2014;4:a013623. [PMID: 25183851 DOI: 10.1101/cshperspect.a013623] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
32 Botchkarev VA, Flores ER. p53/p63/p73 in the epidermis in health and disease. Cold Spring Harb Perspect Med 2014;4:a015248. [PMID: 25085956 DOI: 10.1101/cshperspect.a015248] [Cited by in Crossref: 61] [Cited by in F6Publishing: 65] [Article Influence: 7.6] [Reference Citation Analysis]
33 Arjonen A, Kaukonen R, Mattila E, Rouhi P, Högnäs G, Sihto H, Miller BW, Morton JP, Bucher E, Taimen P, Virtakoivu R, Cao Y, Sansom OJ, Joensuu H, Ivaska J. Mutant p53-associated myosin-X upregulation promotes breast cancer invasion and metastasis. J Clin Invest 2014;124:1069-82. [PMID: 24487586 DOI: 10.1172/JCI67280] [Cited by in Crossref: 105] [Cited by in F6Publishing: 102] [Article Influence: 13.1] [Reference Citation Analysis]
34 Song IY, Balmain A. Cellular reprogramming in skin cancer. Semin Cancer Biol 2015;32:32-9. [PMID: 24721247 DOI: 10.1016/j.semcancer.2014.03.006] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
35 Zhong R, Pytynia M, Pelizzari C, Spiotto M. Bioluminescent imaging of HPV-positive oral tumor growth and its response to image-guided radiotherapy. Cancer Res 2014;74:2073-81. [PMID: 24525739 DOI: 10.1158/0008-5472.CAN-13-2993] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
36 Said R, Hong DS, Warneke CL, Lee JJ, Wheler JJ, Janku F, Naing A, Falchook GS, Fu S, Piha-Paul S, Tsimberidou AM, Kurzrock R. P53 mutations in advanced cancers: clinical characteristics, outcomes, and correlation between progression-free survival and bevacizumab-containing therapy. Oncotarget 2013;4:705-14. [PMID: 23670029 DOI: 10.18632/oncotarget.974] [Cited by in Crossref: 79] [Cited by in F6Publishing: 77] [Article Influence: 9.9] [Reference Citation Analysis]
37 Schramek D, Sendoel A, Segal JP, Beronja S, Heller E, Oristian D, Reva B, Fuchs E. Direct in vivo RNAi screen unveils myosin IIa as a tumor suppressor of squamous cell carcinomas. Science 2014;343:309-13. [PMID: 24436421 DOI: 10.1126/science.1248627] [Cited by in Crossref: 157] [Cited by in F6Publishing: 171] [Article Influence: 19.6] [Reference Citation Analysis]
38 Savar A, Acin S, Gonzalez CL, El-Sawy T, Mejia O, Li Z, Esmaeli B, Lacy-Hulbert A, El-Naggar AK, McCarty JH, Caulin C. Loss of epithelial p53 and αv integrin cooperate through Akt to induce squamous cell carcinoma yet prevent remodeling of the tumor microenvironment. Oncogene 2015;34:516-24. [PMID: 24469034 DOI: 10.1038/onc.2013.585] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
39 Drosten M, Lechuga CG, Barbacid M. Genetic analysis of Ras genes in epidermal development and tumorigenesis. Small GTPases 2013;4:236-41. [PMID: 24150175 DOI: 10.4161/sgtp.26905] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
40 Cui CB, Gerber DA. Donor-associated malignancy in kidney transplant patients. J Clin Invest 2013;123:3708-9. [PMID: 23979157 DOI: 10.1172/JCI70438] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
41 Page ME, Lombard P, Ng F, Göttgens B, Jensen KB. The epidermis comprises autonomous compartments maintained by distinct stem cell populations. Cell Stem Cell 2013;13:471-82. [PMID: 23954751 DOI: 10.1016/j.stem.2013.07.010] [Cited by in Crossref: 194] [Cited by in F6Publishing: 187] [Article Influence: 21.6] [Reference Citation Analysis]
42 Blanpain C. Tracing the cellular origin of cancer. Nat Cell Biol 2013;15:126-34. [DOI: 10.1038/ncb2657] [Cited by in Crossref: 184] [Cited by in F6Publishing: 167] [Article Influence: 20.4] [Reference Citation Analysis]
43 Collins MA, Brisset JC, Zhang Y, Bednar F, Pierre J, Heist KA, Galbán CJ, Galbán S, di Magliano MP. Metastatic pancreatic cancer is dependent on oncogenic Kras in mice. PLoS One 2012;7:e49707. [PMID: 23226501 DOI: 10.1371/journal.pone.0049707] [Cited by in Crossref: 111] [Cited by in F6Publishing: 106] [Article Influence: 11.1] [Reference Citation Analysis]
44 Roshan A, Jones PH. Chronic low dose UV exposure and p53 mutation: tilting the odds in early epidermal preneoplasia? Int J Radiat Biol 2012;88:682-7. [PMID: 22671441 DOI: 10.3109/09553002.2012.699697] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
45 Sotiropoulou PA, Blanpain C. Development and homeostasis of the skin epidermis. Cold Spring Harb Perspect Biol 2012;4:a008383. [PMID: 22751151 DOI: 10.1101/cshperspect.a008383] [Cited by in Crossref: 50] [Cited by in F6Publishing: 54] [Article Influence: 5.0] [Reference Citation Analysis]
46 Napoli M, Girardini JE, Piazza S, Del Sal G. Wiring the oncogenic circuitry: Pin1 unleashes mutant p53. Oncotarget 2011;2:654-6. [PMID: 21926448 DOI: 10.18632/oncotarget.329] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
47 Hanel W, Moll UM. Links between mutant p53 and genomic instability. J Cell Biochem 2012;113:433-9. [PMID: 22006292 DOI: 10.1002/jcb.23400] [Cited by in Crossref: 112] [Cited by in F6Publishing: 122] [Article Influence: 11.2] [Reference Citation Analysis]
48 Park E, Liu B, Xia X, Zhu F, Jami WB, Hu Y. Role of IKKα in skin squamous cell carcinomas. Future Oncol 2011;7:123-34. [PMID: 21174543 DOI: 10.2217/fon.10.166] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
49 Torchia EC, Caulin C, Acin S, Terzian T, Kubick BJ, Box NF, Roop DR. Myc, Aurora Kinase A, and mutant p53(R172H) co-operate in a mouse model of metastatic skin carcinoma. Oncogene 2012;31:2680-90. [PMID: 21963848 DOI: 10.1038/onc.2011.441] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
50 Acin S, Li Z, Mejia O, Roop DR, El-Naggar AK, Caulin C. Gain-of-function mutant p53 but not p53 deletion promotes head and neck cancer progression in response to oncogenic K-ras. J Pathol 2011;225:479-89. [PMID: 21952947 DOI: 10.1002/path.2971] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 3.3] [Reference Citation Analysis]
51 Chen J, O'Shea C, Fitzpatrick JE, Koster MI, Koch PJ. Loss of Desmocollin 3 in skin tumor development and progression. Mol Carcinog 2012;51:535-45. [PMID: 21681825 DOI: 10.1002/mc.20818] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
52 Sankala H, Vaughan C, Wang J, Deb S, Graves PR. Upregulation of the mitochondrial transport protein, Tim50, by mutant p53 contributes to cell growth and chemoresistance. Arch Biochem Biophys 2011;512:52-60. [PMID: 21621504 DOI: 10.1016/j.abb.2011.05.005] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
53 White AC, Tran K, Khuu J, Dang C, Cui Y, Binder SW, Lowry WE. Defining the origins of Ras/p53-mediated squamous cell carcinoma. Proc Natl Acad Sci U S A 2011;108:7425-30. [PMID: 21502519 DOI: 10.1073/pnas.1012670108] [Cited by in Crossref: 127] [Cited by in F6Publishing: 127] [Article Influence: 11.5] [Reference Citation Analysis]
54 Lapouge G, Youssef KK, Vokaer B, Achouri Y, Michaux C, Sotiropoulou PA, Blanpain C. Identifying the cellular origin of squamous skin tumors. Proc Natl Acad Sci U S A 2011;108:7431-6. [PMID: 21502497 DOI: 10.1073/pnas.1012720108] [Cited by in Crossref: 200] [Cited by in F6Publishing: 193] [Article Influence: 18.2] [Reference Citation Analysis]
55 Mukhopadhyay A, Krishnaswami SR, Yu BD. Activated Kras alters epidermal homeostasis of mouse skin, resulting in redundant skin and defective hair cycling. J Invest Dermatol 2011;131:311-9. [PMID: 20944652 DOI: 10.1038/jid.2010.296] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
56 Oren M, Rotter V. Mutant p53 gain-of-function in cancer. Cold Spring Harb Perspect Biol 2010;2:a001107. [PMID: 20182618 DOI: 10.1101/cshperspect.a001107] [Cited by in Crossref: 431] [Cited by in F6Publishing: 472] [Article Influence: 35.9] [Reference Citation Analysis]
57 García-Escudero R, Martínez-Cruz AB, Santos M, Lorz C, Segrelles C, Garaulet G, Saiz-Ladera C, Costa C, Buitrago-Pérez A, Dueñas M, Paramio JM. Gene expression profiling of mouse p53-deficient epidermal carcinoma defines molecular determinants of human cancer malignancy. Mol Cancer 2010;9:193. [PMID: 20630075 DOI: 10.1186/1476-4598-9-193] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
58 Freytag J, Wilkins-Port CE, Higgins CE, Carlson JA, Noel A, Foidart JM, Higgins SP, Samarakoon R, Higgins PJ. PAI-1 Regulates the Invasive Phenotype in Human Cutaneous Squamous Cell Carcinoma. J Oncol 2009;2009:963209. [PMID: 20204159 DOI: 10.1155/2009/963209] [Cited by in Crossref: 14] [Cited by in F6Publishing: 23] [Article Influence: 1.2] [Reference Citation Analysis]
59 Malkoski SP, Cleaver TG, Lu SL, Lighthall JG, Wang XJ. Keratin promoter based gene manipulation in the murine conducting airway. Int J Biol Sci 2010;6:68-79. [PMID: 20140084 DOI: 10.7150/ijbs.6.68] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
60 Whibley C, Pharoah PD, Hollstein M. p53 polymorphisms: cancer implications. Nat Rev Cancer. 2009;9:95-107. [PMID: 19165225 DOI: 10.1038/nrc2584] [Cited by in Crossref: 427] [Cited by in F6Publishing: 412] [Article Influence: 32.8] [Reference Citation Analysis]
61 Chen J, Roop DR. Genetically engineered mouse models for skin research: taking the next step. J Dermatol Sci 2008;52:1-12. [PMID: 18511240 DOI: 10.1016/j.jdermsci.2008.03.012] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
62 Owens DM. p53, chemokines, and squamous cell carcinoma. J Clin Invest 2007;117:1752-5. [PMID: 17607351 DOI: 10.1172/JCI32719] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]